The Human Phenotype Ontology (HPO) provides the following list of features that have been reported in people with this condition. Much of the information in the HPO comes from Orphanet, a European rare disease database. If available, the list includes a rough estimate of how common a feature is (its frequency). Frequencies are based on a specific study and may not be representative of all studies. You can use the MedlinePlus Medical Dictionary for definitions of the terms below.
| Signs and Symptoms | Approximate number of patients (when available) |
| Abnormality of the foot | - |
| Abnormality of the immune system | - |
| Acral ulceration and osteomyelitis leading to autoamputation of digits | - |
| Acute hepatic failure | - |
| Areflexia | - |
| Ataxia | - |
| Autosomal recessive inheritance | - |
| Cirrhosis | - |
| Decreased number of peripheral myelinated nerve fibers | - |
| Diarrhea | - |
| Distal muscle weakness | - |
| Dystonia | - |
| Elevated hepatic transaminases | - |
| Failure to thrive | - |
| Hepatomegaly | - |
| Hypoglycemia | - |
| Hyporeflexia | - |
| Increased susceptibility to fractures | - |
| Infantile onset | - |
| Lactic acidosis | - |
| Macrovesicular hepatic steatosis | - |
| Microvesicular hepatic steatosis | - |
| Muscular hypotonia | - |
| Nystagmus | - |
| Osteomyelitis leading to amputation due to slow healing fractures | - |
| Pain insensitivity | - |
| Painless fractures due to injury | - |
| Phenotypic variability | - |
| Progressive | - |
| Prolonged neonatal jaundice | - |
| Recurrent corneal erosions | - |
| Reye syndrome-like episodes | - |
| Sensorimotor neuropathy | - |
| Short stature | - |
| Vomiting | - |
Making a diagnosis for a genetic or rare disease can often be challenging. Healthcare professionals typically look at a person’s medical history, symptoms, physical exam, and laboratory test results in order to make a diagnosis. The following resources provide information relating to diagnosis and testing for this condition. If you have questions about getting a diagnosis, you should contact a healthcare professional.
The resources below provide information about treatment options for this condition. If you have questions about which treatment is right for you, talk to your healthcare professional.
Research helps us better understand diseases and can lead to advances in diagnosis and treatment. This section provides resources to help you learn about medical research and ways to get involved.
Living with a genetic or rare disease can impact the daily lives of patients and families. These resources can help families navigate various aspects of living with a rare disease.
These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.
Nutritional Interventions in Primary Mitochondrial Disorders: Developing an Evidence Base
Tuesday, December 2, 2014 -
Wednesday, December 3, 2014
Location: NIH Campus,
Bethesda,
MD
Description: The goal of this meeting is to explore the use of nutritional interventions, including dietary supplements, in primary mitochondrial disorders (PMD); identify gaps in knowledge; develop a research agenda; and identify research opportunities to promote an evidence base for the use of nutritional interventions in primary mitochondrial disorders.
Contact: Kathryn Camp, MS, RD, CSP,(301) 435-3608, campkm@od.nih.gov
Co-funding Institute(s): Office of Dietary Supplements, Office of Rare Diseases Research
2013 Neurobiology of Disease in Children Symposium: Mitochondrial Disease
Wednesday, October 30, 2013 -
Wednesday, October 30, 2013
Location:
Austin,
TX
Description: The topic for the 2013 NDC Symposium is Mitochondrial Disease. The NDC Symposium is a forum for preeminent investigators assembled to discuss recent accomplishments and future directions with a large group of child neurologists, program officers from the National Institutes of Health, and members of dedicated foundations and associations.
Contact:
Co-funding Institute(s): National Institute of Neurological Disorders and Stroke, Office of Rare Diseases Research
- 38KB)
